Compare stocks
Add stockDates End of financial period
| #1 | #2 | #3 | #4 | #5 | #6 | #7 | #8 | |
|---|---|---|---|---|---|---|---|---|
| Remove Northrop Grumma... | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 |
| Remove Bristol Myers S... | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 |
| Remove Jpmorgan Chase ... | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 |
Profit ROIC / ROE/ROA / ROE / ROA
| #1 | #2 | #3 | #4 | |
|---|---|---|---|---|
| Northrop Grumman Corp (ROIC) | 12.8% | 13.2% | 13.6% | 11.3% |
| Bristol Myers Squibb Co (ROE/ROA) | 80.6% | 77.5% | 44.5% | 41.0% |
| Jpmorgan Chase & Co (ROE) | 17.3% | 16.8% | 16.6% | 16.4% |
Growth Sales and OCF growth / Sales and net income growth
| #1 | #2 | #3 | #4 | |
|---|---|---|---|---|
| Northrop Grumman Corp | 24.5% | 14.1% | 4.6% | -8.4% |
| Bristol Myers Squibb Co | -6.8% | -1.8% | -3.0% | 4.9% |
| Jpmorgan Chase & Co | 13.7% | 1.5% | 0.7% | 5.1% |
Payout Shareholder distributions / net income
| #1 | #2 | #3 | #4 | #5 | |
|---|---|---|---|---|---|
| Northrop Grumman Corp | 55% | 63% | 76% | 90% | 91% |
| Bristol Myers Squibb Co | 64% | 75% | 290% | 307% | 500% |
| Jpmorgan Chase & Co | 75% | 78% | 75% | 70% | 65% |
Safety Equity/assets and OCF stability / Equity/assets and net income stability
| Balance | Stability | |
|---|---|---|
| Northrop Grumman Corp | 33.9% | 40.6% |
| Bristol Myers Squibb Co | 23.1% | 80.1% |
| Jpmorgan Chase & Co | 7.6% | 92.0% |
Price Earnings and FCF yield / Earnings and book yield
| Earnings | FCF / Book | |
|---|---|---|
| Northrop Grumman Corp | $6.04 | $4.90 |
| Bristol Myers Squibb Co | $7.23 | $8.91 |
| Jpmorgan Chase & Co | $7.25 | $41.75 |
